Neoprobe Planning RIGS Colorectal Cancer Detection Phase III Trial With FDA
This article was originally published in The Gray Sheet
Executive Summary
Neoprobe will meet with FDA in late summer to discuss a proposed Phase III trial protocol for its RIGS technology for colorectal cancer detection